Achyranthes Bidentata Extract Market Forecast, 2022 - 2027

Achyranthes bidentata Extract Market size is estimated to reach $13.2 billion by 2027, growing at a CAGR of 4.5% during the forecast period 2022-2027. Achyranthes bidentata can be delineated as a flowering plant or herb which belongs to the Amaranthaceae family and exhibit several medicinal properties. Saponin like achyranthes bidentata has all-embracing applications in outmoded Chinese therapeutic treatments. Liquid decoctions of achyranthes bidentata which are fabricated by smashing the roots and then administrating with boiling water, are the most common form of herbal medicines and are usually consumed orally. These plants contain products like triterpenoid saponins that hold properties to alter the adverse effects of morbific bacteria. Saponins extend several applications in diminishing cancer risks. Moreover, they help in treating blood anomalies by lowering the lipids in blood and impeding the accretion of the platelet. Saponins are equivalent to an antidote in order to treat someone inflicted with lead poisoning. Considering the widescale application of such analgesics in pharmaceuticals, the achyranthes bidentata extracts market outlook is fairly captivating. The augmenting cerebrovascular diseases, blood disorders, cancer prevalence, and arthritis are factors set to drive the growth of the Achyranthes Bidentata Extract Market for the period 2022-2027.

Download Report Sample

Report Coverage

The report: “Achyranthes Bidentata Extract Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Achyranthes Bidentata Extract Market.

By Product Type: Organic and Inorganic.

By FormSolid, Powder, and Fluid/Liquid.


By GeographyNorth America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America) and Rest of World (the Middle East and Africa).

Key Takeaways

  • Geographically, the Asia-Pacific Achyranthes Bidentata Extract Market accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027.

  • Enlarging complications of dental caries and other serious health hitches is said to be a preeminent driver in Asian countries driving the growth of the Achyranthes Bidentata Extract Market. Lack of consciousness among people regarding such herbal plants and Inadequate availability is said to reduce the market growth.

  • Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Achyranthes Bidentata Extract Market report. 


  • Achyranthes Bidentata Extract Market Challenges

    Limited production and environmental challenges are Anticipated to Hamper Market Growth.

    The achyranthes bidentata has a very limited production as it is found only in a few Asian countries including India, China, and Nepal. Therefore, the supply chain is totally dependent upon 3 or 4 nations. As there is a saying which goes “never put all your eggs in the same basket”, referring to that diversification is important. However, herbal medicines industries operating throughout the globe have no choice as the herb exists only in the Asian continent. On another hand, climatic anomalies such as excess rain, droughts, and disturbed seasonal balance are deteriorating the yield of achyranthes bidentata thus impeding the market growth.

    Achyranthes Bidentata Extract Industry Outlook:

    Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Achyranthes Bidentata Extract Market. Key companies of this market encompass:

    1. Blackmores Ltd.
    2. Mayway Copropration
    3. Lanzhou Wallets Biotech
    4. Cactus Botanics
    5. Hawaii-pharm
    6. Novoherb Technologies
    7. Schaper & Brummer
    8. The Good Scents Company
    9. Botanical Cube Inc.
    10. RD Health Ingredients Co., Ltd.

    Recent Developments

    • On June 16, 2021, after 35 relevant clinical trials, researchers in India discovered the high efficacy of a total of 22 traditional Indian herb plants including “Achyranthes Bidentata” against severe acute respiratory syndrome, COVID-19, and influenza. The researcher claimed that these herbs have proper potential in generating more effective treatment therapies.
    • On April 23, 2021, Germany-based “Schaper & Brummer”, a company which is specialized in herbal medicines announced its acquisition by German health care firm “Medice Arzneimittel Puetter.” In this transaction, Medice acquired a controlling stake by purchasing 60% of the shares for an undisclosed price.
    • On October 27, 2020, New South Wales, Australia-based health supplement firm “Blackmores” announced the disinvestment of one of its subsidiaries “Global Therapeutics” to Australian health corporation “McPherson’s Ltd.” Global therapeutics is famous for its Chinese herbal therapeutic medications. Blackmores will receive $27 million for this transaction.

  • Buy Now

  • "We also publish more than 100 reports every month in “Food and Beverage”, Go through the Domain if there are any other areas for which you would like to get a market research study."


Comments

Popular posts from this blog

Power Transformer Market - By Rating , By Cooling Type , By Phase Configuration , By Technology , By Insulation Type , By Application, By Geography - Global Opportunity Analysis & Industry Forecast, 2024-2030”

Freight Forwarding Market- By Service Type , By Delivery Mode , By Application and By Geography - Opportunity Analysis & Industry Forecast, 2024-2030.

Accounts Payable Automation Market - Forecast(2025 - 2031)